Marking 10 years of “groundbreaking” voluntary licensing agreements for human immunodeficiency virus treatments, ViiV Healthcare and Medicines Patent Pool have announced a fruitful milestone.
The collaboration, which started in 2014, has distributed more than 1 billion packs of generic dolutegravir-based medicines to 24 million people with HIV in 128 low- and middle-income countries
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?